pmcc logo smlHere are the staff publications for September 2016, compiled October 4th.



Here are the staff publications for September 2016, compiled October 4th.


  1. Andreis D, Bonardi S, Allevi G, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer. Breast 2016;29:55-61.
  2. Barkati M, King B, Fortin I, et al. Intensity Modulated Radiation Therapy for Vulvar Carcinoma: Changes in Practice Over 5 Years. International Journal of Radiation Oncology Biology Physics 2016;96:E295-E6.
  3. Castillo JJ, Garcia-Sanz R, Hatjiharissi E, et al. Recommendations for the diagnosis and initial evaluation of patients with Waldenstrom Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenstrom Macroglobulinaemia. British Journal of Haematology 2016;175:77-86.
  4. Chau R, Dashti SG, Ait Ouakrim D, et al. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome. International journal of epidemiology 2016;45:940-53.
  5. Cross NC, White HE, Ernst T, et al. Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale. Leukemia 2016;30:1844-52.
  6. Delaney GP, Gandhidasan S, Walton R, Terlich F, Baker D, Currow D. The Pattern of Use of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer in New South Wales, Australia, 2008 to 2012. International Journal of Radiation Oncology Biology Physics 2016;96:266-72.
  7. Denkert C, Wienert S, Poterie A, et al. Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group. Modern Pathology 2016;29:1155-64.
  8. Denton EJ, Hart D, Wainer Z, Wright G, Russell PA, Conron M. Changing trends in diagnosis, staging, treatment and survival in lung cancer: comparison of three consecutive cohorts in an Australian lung cancer centre. Internal Medicine Journal 2016;46:946-54.
  9. Douglas AP, Chen SC, Slavin MA. Emerging infections caused by non-Aspergillus filamentous fungi. Clinical Microbiology and Infection 2016;22:670-80.
  10. Duchnowska R, Peksa R, Radecka B, et al. Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis. Breast Cancer Research 2016;18:43.
  11. Ebert LM, Tan LY, Johan MZ, et al. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis 2016;19:463-86.
  12. Fumagalli D, Wilson TR, Salgado R, et al. Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers. Annals of Oncology 2016;27:1860-6.
  13. Graudins LV, Ly J, Trubiano J, Aung AK. More than skin deep. Ten year follow-up of delayed cutaneous adverse drug reactions (CADR). British Journal of Clinical Pharmacology 2016;82:1040-7.
  14. Grover A, Nicholson JJ, Huitink JM, Riedel B. Perioperative Medicine within the Context of Global Health: A Billion Shades of Grey, Weighing it up, and the Emperor of All Maladies. International anesthesiology clinics 2016;54:4-18.
    Guo L, Zaysteva O, Nie Z, et al. Defining the essential function of FBP/KSRP proteins: Drosophila Psi interacts with the mediator complex to modulate MYC transcription and tissue growth. Nucleic Acids Research 2016;44:7646-58.
  15. Halliday CL, Chen SC, Kidd SE, et al. Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations. International journal of antimicrobial agents 2016;48:453-8.
  16. Harrison SJ, Mainwaring P, Price T, et al. Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results. Clinical Cancer Research 2016;22:4559-66.
  17. Jefford M, Gough K, Drosdowsky A, et al. A Randomized Controlled Trial of a Nurse-Led Supportive Care Package (SurvivorCare) for Survivors of Colorectal Cancer. Oncologist 2016;21:1014-23.
    Koh CE, Badgery-Parker T, Salkeld G, Young JM, Heriot AG, Solomon MJ. Cost-effectiveness of pelvic exenteration for locally advanced malignancy. British Journal of Surgery 2016;103:1548-56.
  18. Lawrenson K, Kar S, McCue K, et al. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications 2016;7:12675.
  19. Loi S, Dafni U, Karlis D, et al. Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial. JAMA Oncology 2016;2:1040-7.
  20. Luen S, Virassamy B, Savas P, Salgado R, Loi S. The genomic landscape of breast cancer and its interaction with host immunity. Breast 2016;29:241-50.
  21. Macann AM, Fua T, Milross CG, et al. Influence of Domiciliary Humidification on Symptom Burden and Feeding Tube Use Up to 2 Years Postradiation Therapy for Head and Neck Cancer: Trans-Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM Randomized Phase 2 Trial Secondary Analysis. International Journal of Radiation Oncology Biology Physics 2016;96:S217-S8.
  22. Mansour M, Haupt S, Chan AL, et al. The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho Signaling. Cancer Research 2016;76:4236-48.
  23. Milgrom SA, Cheah C, Pinnix CC, et al. Acute and Late Toxicity of Bilateral Orbital Irradiation in the Management of Primary Intraocular Lymphoma. International Journal of Radiation Oncology Biology Physics 2016;96:E490.
  24. Miller MS, Mountford SJ, Pinson JA, et al. Development of single and mixed isoform selectivity PI3Kdelta inhibitors by targeting Asn836 of PI3Kdelta. Bioorganic & Medicinal Chemistry Letters 2016;26:4790-4.
  25. Mittal D, Sinha D, Barkauskas D, et al. Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis. Cancer Research 2016;76:4372-82.
  26. Morey AL, Brown B, Farshid G, et al. Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program. Pathology 2016;48:535-42.
  27. Ng SP, Duchesne G, Tai KH, Toner G, Hicks R, Williams SG. Can Positron Emission Tomography (PET) Complement Conventional Staging of Early-Stage Testicular Seminoma? International Journal of Radiation Oncology Biology Physics 2016;96:E253.
  28. Ninkovic S, Cheah CY, Lasocki A, Harrison SJ. Engraftment syndrome manifesting as acute brachial neuropathy following high-dose chemotherapy for management of plasma cell myeloma. Leukemia & Lymphoma 2016;57:2942-5.
  29. Ong WL, Evans SM, Spelman T, Kearns PA, Murphy DG, Millar JL. Comparison of oncological and health-related quality of life outcomes between open and robot-assisted radical prostatectomy for localised prostate cancer - findings from the population-based Victorian Prostate Cancer Registry. BJU International 2016;118:563-9.
  30. Peterson AL, Walker AK, Sloan EK, Creek DJ. Optimized Method for Untargeted Metabolomics Analysis of MDA-MB-231 Breast Cancer Cells. Metabolites 2016;6:E30.
  31. Pollard A, Burchell JL, Castle D, et al. Individualised mindfulness-based stress reduction for head and neck cancer patients undergoing radiotherapy of curative intent: a descriptive pilot study. European Journal of Cancer Care (Engl) 2016.
  32. Ricon I, Hiller JG, Ben-Eliyahu S. The Combined Blockade of beta-Adrenoceptor and COX-2 During the Perioperative Period to Improve Long-term Cancer Outcomes. International anesthesiology clinics 2016;54:72-91.
  33. Riedel B, Sloan E, Forget P. Long-term Consequences of the Acute Neural-Inflammatory Stress Response in the Cancer Surgical Patient: New Findings and Perspectives. International anesthesiology clinics 2016;54:58-71.
  34. Samuels SE, Eisbruch A, Beitler JJ, et al. Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we? European Archives of Otorhinolaryngology 2016;273:2877-94.
  35. Sanjida S, Janda M, Kissane D, et al. A systematic review and meta-analysis of prescribing practices of antidepressants in cancer patients. Psychooncology 2016;25:1002-16.
  36. Siva S, Pham DJ, Tan TH, et al. Principal Analysis of a Phase Ib Trial of Stereotactic Body Radiation Therapy (SBRT) for Primary Kidney Cancer. International Journal of Radiation Oncology Biology Physics 2016;96:S96.
    Terry MB, Phillips KA, Daly MB, et al. Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC). International journal of epidemiology 2016;45:683-92.
  37. van den Bergh RC, van der Kwast TH, de Jong J, et al. Validation of the novel International Society of Urological Pathology 2014 five-tier Gleason grade grouping: biochemical recurrence rates for 3+5 disease may be overestimated. BJU International 2016;118:502-5.
  38. Wigmore T, Gottumukkala V, Riedel B. Making the Case for the Subspecialty of Onco-Anesthesia. International anesthesiology clinics 2016;54:19-28.
  39. Wong E, Ritchie DS, Davis JE. CIK immunotherapy in refractory hematologic malignancies. Leukemia Research 2016;49:60-1.
  40. Yang L, Paul S, Trieu KG, et al. Minibrain and Wings apart control organ growth and tissue patterning through down-regulation of Capicua. Proceedings of the National Academy of Sciences U S A 2016;113:10583-8.